Myb-induced transformation

Critical Reviews in Oncogenesis

Volumn 7, Issue 3-4, 1996, Pages 245-260

  Wolff, Linda ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b MSC 4255 ^*  (United States)

Author keywords

Differentiation; Leukemia; Protooncogene; Transcription factor

Indexed keywords

APOPTOSIS; AVIAN MYELOBLASTOSIS VIRUS; CARBOXY TERMINAL SEQUENCE; GENE INSERTION; LEUKEMOGENESIS; MALIGNANT TRANSFORMATION; MYELOID LEUKEMIA; NONHUMAN; PROTO ONCOGENE; REVIEW; TRANSCRIPTION REGULATION;

EID: 0030390560     PISSN: 08939675     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevOncog.v7.i3-4.60     Document Type: Review

References (126)

1. Anfossi, G., A. M. Gewirtz, and B. Calabretta: An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines. Proc. Natl. Acad. Sci. U.S.A., 86:3379-3383 (1989).
2. Arsura, M., M. M. Luchetti, E. Erba, J. Golay, A. Rambaldi, and M. Introna: Dissociation between p93B-myb and p75c-myb expression during the proliferation and differentiation of human myeloid cell lines. Blood, 83:1778-1790 (1994).
3. Aziz, N., M. R. Miglarese, R. C. Hendrickson, J. Shabanowitz, T. W. Sturgill, D. F. Hunt, and T. P. Bender: Modulation of c-myb-induced transcription activation by a phosphorylation site near the negative regulatory domain. Proc. Natl. Acad. Sci. U.S.A., 92:6429-6433 (1995).
4. Badiani, P., P. Corbella, D. Kioussis, J. Marvel, and K. Weston: Dominant interfering alleles define a role for c-Myb in T-cell development. Genes Dev., 8:770-782 (1994).
5. Belli, B., L. Wolff, V. Nazarov, and H. Fan: Proviral activation of the c-myb protooncogene is detectable in preleukemic mice infected neonatally with Molpney murine leukemia virus but not in resulting end stage T lymphomas. J. Virol., 69:5138-5141 (1995).
6. Bender, T. P., C. B. Thompson, and W. M. Kuehl: Differential expression of c-myb mRNA in murine B lymphomas by a block to transcription elongation. Science, 237:1473-1476 (1987).
7. Bennett, J. D., P. G. Farlie, and R. J. Watson: E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts. Oncogene, 13:1073-1082 (1996).
8. Beug, H., A. von Kirchbach, G. Doderlein, J. F. Conscience, and T. Graf: Chicken hematopoietic cells transformed by seven strains of defective avian leukemia viruses display three distinct phenotypes of differentiation. Cell, 18:375-390 (1979).
9. Beug, H., P. A. Blundell, and T. Graf: Reversibility of differentiation and proliferative capacity in avian myelomonocytic cells transformed by tsE26 leukemia virus. Genes Dev., 1:277-286 (1987).
10. Biedenkapp, H., U. Borgmeyer, A. E. Sippel, and K. H. Klempnauer: Viral myb oncogene encodes a sequence-specific DNA-binding activity. Nature, 335:835-837 (1988).
11. Bies, J., R. Mukhopadhyaya, J. Pierce, and L. Wolff: Only late, nonmitotic stages of granulocyte differentiation in 32Dc13 cells are blocked by ectopic expression of murine c-myb and its truncated forms. Cell Growth Differ., 6:59-68 (1995).
12. Bies, J., B. Huffman, A. Amanullah, T. Giese, and L. Wolff: B-Myb prevents growth arrest associated with terminal differentiation of monocytic cells. Oncogene, 12:355-363 (1996).
13. Bies, J. and L. Wolff: Acceleration of apoptosis in transforming growth factor beta 1-treated M1 cells ectopically expressing B-myb. Cancer Res., 55:501-504 (1995).
14. Bies, J. and L. Wolff: Oncogenic activation of c-Myb by carboxyl-terminal truncation leads to decreased proteolysis by the ubiquitin-26S proteasome pathway. Oncogene, 14:203-212 (1997).
15. Brandt, T. L., D. J. Fraser, S. Leal, P. M. Halandras, A. R. Kroll, and D. J. Kroll: c-Myb trans-activates the human DNA topoisomerase II gene promoter. J. Biol. Chem., 272:6278-6284 (1997).
16. Brown, K. E., M. S. Kindy, and G. E. Sonenshein: Expression of the c-myb protooncogene in bovine vascular smooth muscle cells. J. Biol. Chem., 267:4625-4630 (1992).
17. Burk, O., S. Mink, M. Ringwald, and K. H. Klempnauer: Synergistic activation of the chicken mim-1 gene by v-myb and C/EBP transcription factors. EMBO J., 12:2027-2038 (1993).
18. Chen, R. H., S. Fields, and J. S. Lipsick: Dissociation of transcriptional activation and oncogenic transformation by v-Myb. Oncogene, 11:1771-1779 (1995).
19. Clarke, M. F., J. F. Kukowska-Latallo, E. Westin, M. Smith, and E. V. Prochownik: Constitutive expression of a c-myb cDNA blocks Friend murine erythroleukemia cell differentiation. Mol. Cell Biol., 8:884-892 (1988).
20. Cogswell, J. P., P. C. Cogswell, W. M. Kuehl, A. M. Cuddihy, T. M. Bender, U. Engelke, K. B. Marcu, and J. P. Ting: Mechanism of c-myc regulation by c-Myb in different cell lineages. Mol. Cell Biol., 13:2858-2869 (1993).
21. Coll, J., S. Saule, P. Martin, M. B. Raes, C. Lagrou, T. Graf, H. Beug, I. E. Simon, and D. Stehelin: The cellular oncogenes c-myc, c-myb and c-erb are transcribed in defined types of avian hematopoietic cells. Exp. Cell Res., 149:151-162 (1983).
22. Dai, P., H. Akimaru, Y. Tanaka, D.-X. Hou, T. Yasukawa, C. Kanei-Ishii, T. Takahashi, and S. Ishii: CBP as a transcriptional coactivator of c-Myb. Genes Dev., 10:528-540 (1996).
23. Danish, R., O. el-Awar, B. L. Weber, J. Langmore, L. A. Turka, J. J. Ryan, and M. F. Clarke: c-myb effects on kinetic events during MEL cell differentiation. Oncogene, 7:901-907 (1992).
24. Dash, A. B., F. C. Orrico, and S. A. Ness: The EVES motif mediates both intermolecular and intramolecular regulation of c-Myb. Genes Dev., 10:1858-1869 (1996).
25. Dini, P. W., J. T. Eltman, and J. S. Lipsick: Mutations in the DNA-binding and transcriptional activation domains of v-Myb cooperate in transformation. J. Virol., 69:2515-2524 (1995).
26. Dini, P. W. and J. S. Lipsick: Oncogenic truncation of the first repeat of c-Myb decreases DNA binding in vitro and in vivo. Mol. Cell Biol., 13:7334-7348 (1993).
27. Dudek, H., R. V. Tantravahi, V. N. Rao, E. S. Reddy, and E. P. Reddy: Myb and Ets proteins cooperate in transcriptional activation of the mim-1 promoter. Proc. Natl. Acad. Sci. U.S.A., 89:1291-1295 (1992).
28. Duprey, S. P. and D. Boettiger: Developmental regulation of c-myb in normal myeloid progenitor cells [published erratum appears in Proc Natl Acad Sci USA 1986 Apr; 83(7):2281]. Proc. Natl. Acad. Sci. U.S.A., 82:6937-6941 (1985).
29. Eckert, E. A., D. Beard, and J. W. Beard: Dose-response relations in experimental transmission of anvian erythromyeloblastic leukosis. I. Host-response to the virus. J. Natl. Cancer Inst., 12:447-463 (1951).
30. Ferrao, P., E. M. MacMillan, L. K. Ashman, and T. J. Gonda: Enforced expression of full-length c-Myb leads to density-dependent transformation of murine haemopoietic cells. Oncogene, 11:1631-1638 (1995).
31. Foos, G., S. Natour, and K. H. Klempnauer: TATA-box dependent trans-activation of the human HSP70 promoter by Myb proteins, Oncogene, 8:1775-1782 (1993).
32. Frampton, J., K. McNagny, M. Sieweke, A. Philip, G. Smith, and T. Graf: v-Myb DNA binding is required to block thrombocytic differentiation of Myb-Ets-transformed multipotent hematopoietic progenitors. EMBO J., 14:2866-2875 (1995).
33. Frampton, J., T. Ramqvist, and T. Graf: v-Myb of E26 leukemia virus up-regulates bcl-2 and suppresses appptosis in myeloid cells. Genes Dev., 10:2720-2731 (1996).
34. Gewirtz, A. M. and B. Calabretta: A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro. Science, 242:1303-1306 (1988).
35. Golay, J., A. Capucci, M. Arsura, M. Castellano, V. Rizzo, and M. Introna: Expression of c-myb and B-myb, but not A-myb, correlates with proliferation in human hematopoietic cells. Blood, 77:149-158 (1991).
36. Golay, J., E. Erba, S. Bernasconi, G. Peri, and M. Introna: The A-myb gene is preferentially expressed in tonsillar CD38+, CD39-, and sIgM- B lymphocytes and in Burkitt's lymphoma cell lines. J. Immunol., 153:543-553 (1994).
37. Golay, J., L. Basilico, L. Loffarelli, S. Songia, V. Broccoli, and M. Introna: Regulation of hematopoietic cell proli-feration and differentiation by the myb oncogene family of transcription factors. Int. J. Clin. Lab. Res., 26:24-32 (1996).
38. Gonda, T. J., S. Cory, P. Sobieszczuk, D. Holtzman, and J. M. Adams : Generation of altered transcripts by retroviral insertion within the c-myb gene in two murine monocytic leukemias. J. Virol, 61:2754-2763 (1987).
39. Gonda, T. J., E. M. MacMillan, P. V. Townsend, and A. J. Hapel: Differentiation state and responses to hematopoietic growth factors of murine myeloid cells transformed by myb. Blood, 82:2813-2822 (1993).
40. Graf, T., A. Kirchback, and H. Beug: Characterization of the hematopoietic target cells of AEV, MC29 and AMV avian leukemia viruses. Exp. Cell Res., 131:331-343 (1981).
41. Graf, T., K. McNagny, G. Brady, and J. Frampton: Chicken erythroid cells transformed by the Gag-Myb-Ets-encoding E26 leukemia virus are multipotent. Cell, 70:201-213 (1992).
42. Graf, T. and H. Beug: Avian leukemia viruses. Interaction with their target cells in vivo and in vitro. Biochim. Biophys. Acta, 516:269-299 (1978).
43. Grasser, F. A., T. Graf, and J. S. Lipsick: Protein truncation is required for the activation of the c-myb protooncogene. Mol. Cell Biol., 11:3987-3996 (1991).
44. Hernandez-Munain, C. and M. S. Krangel: Regulation of the T-cell receptor delta enhancer by functional cooperation between c-Myb and core-binding factors. Mol. Cell Biol., 14:473-183 (1994).
45. Hijiya, N. and A. M. Gewirtz: Oncogenes, protooncogenes, and tumor suppressor genes in acute myelogenous leukemia. J. Pediatric Hematol./Oncol., 17:101-112 (1995).
46. Howe, K. M., C. F. Reakes, and R. J. Watson: Characterization of the sequence-specific interaction of mouse c-myb protein with DNA. EMBO J., 9:161-169 (1990).
47. Hsiang, Y. H., J. P. Goldman, and D. H. Raulet: The role of c-Myb or a related factor in regulating the T cell receptor gamma gene enhancer. J. Immunol., 154:5195-5204 (1995).
48. Hu, Y. L., R. G. Ramsay, C. Kanei-Ishii, S. Ishii, and T. J. Gonda: Transformation by carboxyl-deleted Myb reflects increased transactivating capacity and disruption of a negative regulatory domain. Oncogene, 6:1549-1553 (1991).
49. Ibanez, C. E. and J. S. Lipsick: Structural and functional domains of the myb oncogene: requirements for nuclear transport, myeloid transformation, and colony formation. J. Virol, 62:1981-1988 (1988).
50. Introna, M., J. Golay, J. Frampton, T. Nakano, S. A. Ness, and T. Graf: Mutations in v-myb alter the differentiation of myelomonocytic cells transformed by the oncogene. Cell, 63:1289-1297 (1990).
51. Introna, M., M. Luchetti, M. Castellano, M. Arsura, and J. Golay: The myb oncogene family of transcription factors: potent regulators of hematopoeitic cell proliferation and differentiation. Semin. Cancer Biol., 5:113-124 (1994).
52. Ishiguro, N., T. Ohzono, T. Shinagawa, M. Horiuchi, and M. Shinagawa: A spontaneous internal deletion of the c-myb protooncogene enhances transcriptional activation in bovine T lymphoma cells. J. Biol. Chem., 269:26822-26829 (1994).
53. Ivanov, X., Z. Mladenov, S. Nedyalkov, and T. Todorov: Bull. Inst. Pathol. Comp. Animaux, 9:5-36 (1962).
54. Jonkers, J. and A. Berns: Retroviral insertional mutagenesis as a strategy to identify cancer genes. Biochem. Biophys. Acta., 1287:29-57 (1996).
55. Kalkbrenner, F., S. Guehmann, and K. Moelling: Transcriptional activation by human c-myb and v-myb genes. Oncogene, 5:657-661 (1990).
56. Kanei-Ishii, C., E. M. MacMillan, T. Nomura, A. Sarai, R. G. Ramsay, S. Aimoto, S. Ishii, and T. J. Gonda: Transactivation and transformation by Myb are negatively regulated by a leucine-zipper structure. Proc. Natl. Acad. Sci. U.S.A., 89:3088-3092 (1992).
57. Kanter, M. R., R. E. Smith, and W. S. Hayward: Rapid induction of B-cell lymphomas: insertional activation of c-myb by avian leukosis virus. J. Virol., 62:1423-1432 (1988).
58. Koller, R., M. Krall, B. Mock, J. Bies, V. Nazarov, and L. Wolff: Mml1, a new common integration site in murine leukemia virus-induced promonocytic leukemias maps to mouse chromosome 10. Virology, 224:224-234 (1996).
59. Ku, D. H., S. C. Wen, A. Engelhard, N. C. Nicolaides, K. E. Lipson, T. A. Marino, and B. Calabretta: c-myb transactivates cdc2 expression via Myb binding sites in the 5′-flanking region of the human cdc2 gene [published erratum appears in J Biol Chem 1993 Jun 15; 268(17):13010]. J. Biol. Chem., 268:2255-2259 (1993).
60. Lam, E. W., J. D. Bennett, and R. J. Watson: Cell-cycle regulation of human B-myb transcription. Gene, 160:277-281 (1995).
61. Lam, E. W. and R. J. Watson: An E2F-binding site mediates cell cycle-regulated repression of mouse B-myb transcription. EMBO J., 12:2705-2713 (1993).
62. Lam, E. W.-F., C. Robinson, and R. J. Watson: Characterization and cell cycle-regulated expression of mouse B-myb. Oncogene, 7:1885-1890 (1992).
63. Liebermann, D. A. and B. Hoffman-Lieberrnann: Protooncogene expression and dissection of the myeloid growth to differentiation developmental cascade. Oncogene, 4:583-592 (1989).
64. Lin, D., M. T. Shields, S. J. Ullrich, E. Appella, and W. E. Mercer: Growth arrest induced by wild-type p53 pratein blocks cells prior to or near the restriction point in late G1 phase. Proc. Natl. Acad. Sci. U.S.A., 89:9210-9214 (1992).
65. Lyon, J. J. and R. J. Watson: Interference of Myb transactivation activity by a conditional dominant negative protein: functional interference in a cytotoxic T-cell results in G1 arrest. Gene, 182:123-128 (1996).
66. MacMillan, E. M. and T. J. Gonda: Murine myeloid cells transformed by myb require fibroblast-derived or autocrine growth factors in addition to granulocyte-macrophage colony-stimulating factor for proliferation. Blood, 83:209-216 (1994).
67. McCracken, S., S. Leung, R. Bosselut, J. Ghysdael, and N. G. Miyamoto: Myb and Ets related transcription factors are required for activity of the human Ick type I promoter. Oncogene, 9:3609-3615 (1994).
68. Melani, C., L. Rivoltini, G. Parmiani, B. Calabretta, and M. P. Colombo: Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb. Cancer Res., 51:2897-2901 (1991).
69. Melotti, P. and B. Calabretta: Ets-2 and c-Myb act independently in regulating expression of the hematopoietic stem cell antigen CD34. J. Biol. Chem., 269:25303-25309 (1994).
70. Miglarese, M. R., A. F. Richardson, N. Aziz, and T. P. Bender: Differential regulation of c-Myb-induced transcription activation by a phosphorylation site in the negative regulatory domain. J. Biol. Chem., 271:22697-22705 (1996).
71. Mizuguchi, G., C. Kanei-Ishii, T. Takahashi, T. Yasukawa, T. Nagase, M. Horikoshi, T. Yamamoto, and S. Ishii: c-Myb repression of c-erbB-2 transcription by direct binding to the c-efbB-2 promoter. J. Biol. Chem., 270:9384-9389 (1995).
72. Mucenski, M. L., K. McLain, A. B. Kier, S. H. Swerdlow, C. M. Schreiner, T. A. Miller, D. W. Pietryga, W. J. Scott Jr., and S. S. Potter: A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell, 65:677-689 (1991).
73. Mukhopadhyaya, R., J. Richardson, V. Nazarov, A. Corbin, R. Koller, M. Sitbon, and L. Wolff: Different abilities of Friend murine leukemia virus (MuLV) and Moloney MuLV to induce promonocytic leukemia are due to determinants in both psi-gag-PR and env regions. J. Virol., 68:5100-5107 (1994).
74. Mukhopadhyaya, R. and L. Wolff: New sites of proviral integration associated with murine promonocytic leukemias and evidence for alternate modes of c-myb activation. J. Virol., 66:6035-6044 (1992).
75. Nason-Burchenal, K. and L. Wolff: Involvement of the spleen in preleukemic development of a murine retrovirusinduced promonocytic leukemia. Cancer Res., 52:5317-5322 (1992).
76. Nason-Burchenal, K. .and L. Wolff: Activation of c-myb is an early bone marrow event in a murine model for acute promonocytic leukemia. Proc. Natl. Acad. Sci. U.S.A., 90:1619-1623 (1993).
77. Nazarov, V., D. Hilbert, and L. Wolff: Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia. Virology, 205:479-485 (1994).
78. Nazarov, V. and L. Wolff: Novel integration sites at the distal 3′ end of the c-myb locus in retrovirus-induced promonocytic leukemias. J. Virol., 69:3885-3888 (1995).
79. Ness, S. A., A. Marknell, and T. Graf: The v-myb oncogene product binds to and activates the promyelocyte-specific mim-1 gene. Cell, 59:1115-1125 (1989).
80. Ness, S. A., E. Kowenz-Leutz, T. Casini, T. Graf, and A. Leutz: Myb and NF-M: combinatorial activators of myeloid genes in heterologous cell types. Genes Dev., 7:749-759 (1993).
81. Ness, S. A.: The Myb oncoprotein: regulating a regulator. Biochim. Biophysica Acta, 1288:F123-F139 (1996).
82. Nomura, T., Y. Takahasi, M. Matsui, S. Ishii, T. Date, S. Sasmoto, and R. Ishizaki: Isolation of human cDNA clones of myb-related genes, A-myb and B-myb. Nucleic Acids Res., 16:11075-11089 (1988).
83. Oelgeschlager, M., J. Krieg, J. M. Luscher-Firzlaff, and B. Luscher: Casein kinase II phosphorylation site mutations in c-Myb affect DNA binding and transcriptional cooperativity with NF-M. Mol. Cell Biol., 15:5966-5974 (1995).
84. Oelgeschlager, M., R. Janknecht, J. Krieg, S. Schreek, and B. Luscher: Interaction of the co-activator CBP with Myb proteins: effects on Myb-specific transactivation and on the cooperativity with NF-M. EMBO J., 15:2771-2780 (1996a).
85. Oelgeschlager, M., I. Nuchprayoon, B. Luscher, and A. D. Friedman: C/EBP, c-Myb, and PU.l cooperate to regulate the neutrophil elastase promotor. Mol. Cell. Biol., 16:4717-4725 (1996b).
86. Pandolfi, P. P., F. Grignani, M. Alcalay, A. Mencarelli, A. Biondi, F. LoCoco, and P. G. Pelicci: Structure and origin of the acute promyelocytic leukemia myl/RAR alpha cDNA and characterization of its retinoid-binding and transactivation properties. Oncogene, 6:1285-1292 (1991).
87. Payne, L.N.: Biology of avian retroviruses. In: The Retroviridae, Vol. 1. (J. A. Levy, Ed.). Plenum Press, New York, 299-404 (1992).
88. Pizer, E. and E. H. Humphries: RAV-1 insertional mutagenesis: disruption of the c-myb locus and development of avian B-celllymphomas. J. Virol, 63:1630-1640 (1989).
89. Pizer, E. S., T. W. Baba, and E. H. Humphries: Activation of the c-myb locus is insufficient for the rapid induction of disseminated avian B-cell lymphoma. J. Virol., 66:512-523 (1992).
90. Press, R. D., T. W. Wisner, and D. L. Ewert: Induction of B cell lymphomas by overexpression of a Myb oncogene truncated at either terminus. Oncogene, 11:525-535 (1995).
91. Raschella, G., A. Negroni, T. Skorski, S. Pucci, M. Nieborowska-Skorska, A. Romeo, and B. Calabretta: Inhibition of proliferation by c-myb antisense RNA and oligodeoxynucleotides in transformed neuroectodermal cell lines. Cancer Res., 52:4221-4226 (1992).
92. Reddy, C. D. and E. P. Reddy : Differential binding of nuclear factors to the intron 1 sequences containing the transcriptional pause site correlates with c-myb expression. Proc. Natl. Acad. Sci. U.S.A., 86:7326-7330 (1989).
93. Reddy, M. A., B. S. Yang, X. Yue, C. J. Barnett, I. L. Ross, M. J. Sweet, D. A. Hume, and M. C. Ostrowski: Opposing actions of c-ets/PU. 1 and c-myb protooncogene products in regulating the macrophage-specific promoters of the human and mouse colony-stimulating factor-1 receptor (c-fms) genes. J. Exp. Med., 180:2309-2319 (1994).
94. Reiss, K., S. Travail, B. Calabretta, and R. Baserga: Growth-regulated expression of B-myb in fibroblasts and hematopoietic cells. J. Cell Physiol., 148:338-343 (1991).
95. Rose, F. V. and E. P. Reddy: Abrogation of IL-2 dependence by recombinant murine retrovirus containing v-myb. Virology, 188:650-656 (1992).
96. Rouzic, E. and B. Perbal: Retroviral insertional activation of the c-myb protooncogene in a Marek's disease T-lymphoma cell line. J. Virol., 70:7414-7423 (1996).
97. Ruscetti, S., R. Aurigemma, C. C. Yuan, S. Sawyer, and D. G. Blair: Induction of erythropoietin responsiveness in murine hematopoietic cells by the gag-myb-ets-containing ME26 virus. J. Virol., 66:20-26 (1992).
98. Sakura, H., C. Kanei-Ishii, T. Nagase, H. Nakagoshi, T. J. Gonda, and S. Ishii: Delineation of three functional domains of the transcriptional activator encoded by the c-myb protooncogene. Proc. Natl. Acad. Sci. U.S.A., 86:5758-5762 (1989).
99. Sala, A., I. Casella, T. Bellon, B. Calabretta, R. J. Watson, and C. Peschle: B-myb promotes S phase and is a downstream target of the negative regulator p 107 in human cells. J. Biol. Chem., 271:9363-9367 (1996).
100. Sala, A. and B. Calabretta: Regulation of BALB/c 3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin. Proc. Natl. Acad. Sci. U.S.A., 89:10415-10419 (1992).
101. Selvakumaran, M., D. A. Liebermann, and B. Hoffman-Liebermann: Deregulated c-myb disrupts interleukin-6or leukemia inhibitory factor-induced myeloid differentiation prior to c-myc: role in leukemogenesis. Mol. Cell. Biol., 12:2493-2500 (1992).
102. Selvakumaran, M., H.-L. Lin, R. T. T. Sjin, J. C. Reed, D. A. Liebermann, and B. N. Hoffman: The novel primary response gene MyD188 protooncogenes myb, myc, and bcl-2 modulate transforming growth factor 1-induced apoptosis of myeloid leukemia cells. Mol. Cell. Biol., 14:2352-2360 (1994).
103. Shapiro, L. H.: .Myb and Ets proteins cooperate to transactivate an early myeloid gene. J. Biol. Chem., 270:8763-8771 (1995).
104. Sheiness,D. andM. Gardinier: Expression of a protooncogene (proto-myb) in hemopoietic tissues of mice. Mol. Cell Biol., 4:1206-1212 (1984).
105. Shen-Ong, G. L., H. C. Morse, III, M. Potter, and J. F. Mushinski: Two modes of c-myb activation in virusinduced mouse myeloid tumors [published erratum appears in Mol. Cell Biol 1986 Jul; 6(7):2756]. Mol. Cell Biol., 6:380-392 (1986).
106. Shen-Ong, G. L. and L. Wolff: Moloney murine leukemia virus-induced myeloid tumors in adult BALB/c mice: requirement of c-myb activation but lack of v-abl involvement. J. Virol, 61:3721-3725 (1987).
107. Sitzmann, J., K. Noben-Trauth, and K. H. Klempnauer: Expression of mouse c-myb during embryonic development. Oncogene, 11:2273-2279 (1995).
108. Siu, G., A. L. Wurster, J. S. Lipsick, and S. M. Hedrick: Expression of the CD4 gene requires a Myb transcription factor. Mol. Cell Biol., 12:1592-1604 (1992).
109. Stern, J. B. and K. A. Smith: Interleukin-2 induction of T-cell G1 progression and c-myb expression. Science, 233:203-206 (1986).
110. Tantravahi, R., H. Dudek, G. Patel, and E. P. Reddy: Murine myeloid leukemic cells with disrupted myb loci show splicing anomalies that account for heterogeneous sizes in myb proteins. Oncogene, 13:1187-1196 (1996).
111. Taylor, D., P. Badiani, and K. Weston: A dominant interfering Myb mutant causes apoptosis in T cells. Genes Dev., 10:2732-2744 (1996).
112. Thompson, M. A. and R. G. Ramsay: Myb: an old oncoprotein with new roles. BioEssays, 17:341-350 (1995).
113. Torelli, G., L. Selleri, A. Donelli, S. Ferrari, G. Emilia, D. Venturelli, L. Moretti, and U. Torelli: Activation of c-myb expression by phytohemagglutinin stimulation in normal human T lymphocytes. Mol. Cell Biol., 5:2874-2877 (1985).
114. Travail, S., K. Reiss, A. Ferber, S. Petralia, W. E. Mercer, B. Calabretta, and R. Baserga: Constitutively expressed c-myb abrogates the requirement for insulinlike growth factor 1 in 3T3 fibroblasts. Mol. Cell Biol., 11:731-736 (1991).
115. Vandenbark, G. R., Y. Chen, E. Friday, K. Pavlik, B. Anthony, C. deCastro, and R. E. Kaufman: Complex regulation of human c-kit transcription by promoter repressers, activators, and specific myb elements. Cell Growth Differ., 7:1383-1392 (1996).
116. Wang, L. G., X. M. Liu, Z. R. Li, S. Denstman, and A. Bloch: Differential binding of nuclear c-ets-1 protein to an intron I fragment of the c-myb gene in growth versus differentiation. Cell Growth Differ., 5:1243-1251 (1994).
117. Watson, R. J.: A transcriptional arrest mechanism involved in controlling constitutive levels of mouse c-myb mRNA. Oncogene, 2:267-272 (1988).
118. Weinstein, Y., J. L. Cleveland, D. S. Askew, U. R. Rapp, and J. N. Ihle: Insertion and truncation of c-myb by murine leukemia virus in a myeloid cell line derived from cultures of normal hematopoietic cells. J. Virol., 61:2339-2343 (1987).
119. Weston, K. and J. M. Bishop: Transcriptional activation by the v-myb oncogene and its cellular progenitor, c-myb. Cell, 58:85-93 (1989).
120. Weston, K. M.: The myb genes. Semin. Cancer Biol., 1:371-382 (1990).
121. Wolff, L., J. F. Mushinski, G. L. Shen-Orig, and H. C. Morse III: A chronic inflammatory response. Its role in supporting the development of c-myb and c-myc related promonocytic and monocytic tumors in BALB/c mice. J. Immunol., 141:681-689 (1988).
122. Wolff, L., R. Koller, and W. Davidson: Acute myeloid leukemia induction by amphotropic murine retrovirus (4070A): clonal integrations involve c-myb in some but not all leukemias. J. Virol., 65:3607-3616 (1991).
123. Wolff, L., R. Koller, J. Bies, V. Nazarov, B. Huffman, A. Amanullah, M. Krall, and A. Mock: Retroviral insertional mutagenesis in murine promonocytic leukemias: c-myb and Mml1. Curr. Topics Microbiol. Immunol., 211:191-199 (1996).
124. Wolff, L. and R. Koller: Regions of the Moloney murine leukemia virus genome specifically related to induction of promonocytic tumors. J. Virol., 64:155-160 (1990).
125. Yanagisawa, H., T. Nagasawa, S. Kuramochi, T. Abe, Y. Ikawa, and K. Todokoro: Constitutive expression of exogenous c-myb gene causes maturation block in monocyte-macrophage differentiation. Biochim. Biophys. Acta, 1088:380-384 (1991).
126. Zobel, A., F. Kalkbrenner, G. Vorbrueggen, and K. Moelling: Transactivation of the human c-myc gene by c-Myb. Biochem. Biophys. Res. Commun., 186:715-722 (1992).